title: Cutaneous malignancies in immunosuppressed organ transplant recipients.
abstract: During the past century, organ transplantation has delivered the miracle of life to more than 500,000 patients in need. Secondary malignancies have developed as an unforeseen consequence of intense immunosuppressive regimens. Cutaneous malignancies have been recognized as the most frequent cancer that arises post-transplantation. Among organ transplant recipients (OTRs), skin cancer is a substantial cause of morbidity and potential mortality. The authors discuss epidemiology and clinical presentation of cutaneous malignancies; associated risk factors; recommendation for the care of immunosuppressed OTRs, and emerging therapies on the horizon.
authors.forename: Ivette M Sosa
authors.initials: IM
authors.lastname: Seda
authors.forename: Adeel
authors.initials: A
authors.lastname: Zubair
authors.forename: Jerry D
authors.initials: JD
authors.lastname: Brewer
mesh_terms: D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D016377:Organ Transplantation / Q000379:methods*; D012307:Risk Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology
chemical_list: D007166:Immunosuppressive Agents